Joachim Morrens
Biographic Data
| ID | 7964577 |
|---|---|
| NAME | Joachim Morrens |
| GIVEN NAMES | Joachim |
| FAMILY NAME | Morrens |
| SIGNATURE | MORRENS J |
| AFFILIATIONS | Janssen (Belgium) |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Iceberg study
ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video
Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression
Introduction: Treatment-resistant depression (TRD) is a debilitating condition affecting 20-30% of patients with major depressive disorders (MDD). Currently, there is no established standard of care for TRD, and wide variation in the clinical approach for disease management has been documented. Real-world data could help describe TRD clinical features, disease burden, and treatment outcome and identify a potential unmet medical need. Methods: We …
No prominent works on this page.
Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression
Introduction: Treatment-resistant depression (TRD) is a debilitating condition affecting 20-30% of patients with major depressive disorders (MDD). Currently, there is no established standard of care for TRD, and wide variation in the clinical approach for disease management has been documented. Real-world data could help describe TRD clinical features, disease burden, and treatment outcome and identify a potential unmet medical need. Methods: We …
Iceberg study
ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video
Depression (economics (2 works) · Internal Medicine (2 works) · Major depressive disorder (2 works) · Medicine (2 works) · Treatment of Major Depression (2 works) · Treatment-resistant depression (2 works) · Tryptophan and brain disorders (2 works) · Anesthesia (1 work) · Antidepressant (1 work) · Bipolar Disorder and Treatment (1 work)